• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

HHS, DEA still at odds over e-prescribing


The Department of Health & Human Services approved foundation standards for electronic prescribing in January and is pushing hard for widespread adoption of e-prescribing. But across the Potomac River from HHS' downtown Washington headquarters, the Drug Enforcement Administration has serious fears about controlled substances being e-prescribed. It has indicated, for example, that further security measures may need to be in place before controlled-substance e-prescribing is allowed to go forward.

Related Videos
Dr. Charles Lee
Dr. Charles Lee
Dr. Charles Lee
Related Content
© 2023 MJH Life Sciences

All rights reserved.